Authors:
GARDNER LI
HARRISON SH
HENDRIX CW
BLATT SP
WAGNER KF
CHUNG RCY
HARRIS RW
COHN DL
BURKE DS
MAYERS DL
Citation: Li. Gardner et al., SIZE AND DURATION OF ZIDOVUDINE BENEFIT IN 1003 HIV-INFECTED PATIENTS- US ARMY, NAVY, AND AIR-FORCE NATURAL-HISTORY DATA, Journal of acquired immune deficiency syndromes and human retrovirology, 17(4), 1998, pp. 345-353
Authors:
PORTER KR
MASCOLA JR
HUPUDIO H
EWING D
VANCOTT TC
ANTHONY RL
CORWIN AL
WIDODO S
ERTONO S
MCCUTCHAN FE
BURKE DS
HAYES CG
WIGNALL FS
GRAHAM RR
Citation: Kr. Porter et al., GENETIC, ANTIGENIC AND SEROLOGIC CHARACTERIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 FROM INDONESIA, Journal of acquired immune deficiency syndromes and human retrovirology, 14(1), 1997, pp. 1-6
Authors:
ANDERSON R
BARRESINOUSSI F
BRADAC J
BURKE DS
ESSEX M
FENYO EM
GALVAOCASTRO B
HU DJ
JAFFE H
KARAMOV E
KUIKEN C
KUNANUSONT C
LAGA M
LOWER J
MASTRO T
MCCUTCHAN FE
OPIO A
PAULI G
SUTHERLAND D
SCHWARTLANDER B
DEVINCENZI I
VONBRIESEN H
WASI C
WEBER J
PIOT P
CARAEL M
OSMANOV S
Citation: R. Anderson et al., IMPLICATIONS OF HIV VARIABILITY FOR TRANSMISSION - SCIENTIFIC AND POLICY ISSUES, AIDS, 11(4), 1997, pp. 1-15
Authors:
SALMINEN MO
CARR JK
ROBERTSON DL
HEGERICH P
GOTTE D
KOCH C
SANDERSBUELL E
GAO F
SHARP PM
HAHN BH
BURKE DS
MCCUTCHAN FE
Citation: Mo. Salminen et al., EVOLUTION AND PROBABLE TRANSMISSION OF INTERSUBTYPE RECOMBINANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN A ZAMBIAN COUPLE, Journal of virology, 71(4), 1997, pp. 2647-2655
Authors:
POPE M
FRANKEL SS
MASCOLA JR
TRKOLA A
ISDELL F
BIRX DL
BURKE DS
HO DD
MOORE JP
Citation: M. Pope et al., HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 STRAINS OF SUBTYPE-B AND SUBTYPE-E REPLICATE IN CUTANEOUS DENDRITIC CELL T-CELL MIXTURES WITHOUT DISPLAYING SUBTYPE-SPECIFIC TROPISM, Journal of virology, 71(10), 1997, pp. 8001-8007
Authors:
EVANS JS
NIMS T
COOLEY J
BRADLEY W
JAGODZINSKI L
ZHOU S
MELCHER GP
BURKE DS
VAHEY M
Citation: Js. Evans et al., SERUM LEVELS OF VIRUS BURDEN IN EARLY-STAGE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 DISEASE IN WOMEN, The Journal of infectious diseases, 175(4), 1997, pp. 795-800
Authors:
KIM JH
LOVELAND JE
SITZ KV
KIM SR
MCLINDEN RJ
TENCER K
DAVIS K
BURKE DS
BOSWELL RN
REDFIELD RR
BIRX DL
Citation: Jh. Kim et al., EXPANSION OF RESTRICTED CELLULAR IMMUNE-RESPONSES TO HIV-1 ENVELOPE BY VACCINATION - IL-7 AND IL-12 DIFFERENTIALLY AUGMENT CELLULAR PROLIFERATIVE RESPONSES TO HIV-1, Clinical and experimental immunology, 108(2), 1997, pp. 243-250
Citation: Ds. Burke, SING FOR THE GOVNOR - A CALL TO ADVOCACY FOR TROPICAL MEDICINE AND HYGIENE, The American journal of tropical medicine and hygiene, 56(1), 1997, pp. 1-6
Citation: Jh. Kim et al., TRANSCRIPTIONAL EFFECTS OF SUPERINFECTION IN HIV CHRONICALLY INFECTEDT-CELLS - STUDIES IN DUALLY INFECTED CLONES, Journal of acquired immune deficiency syndromes and human retrovirology, 12(4), 1996, pp. 329-342
Authors:
SIRISOPANA N
TORUGSA K
MASON CJ
MARKOWITZ LE
JUGSUDEE A
SUPAPONGSE T
CHUENCHITRA C
MICHAEL RA
BURKE DS
SINGHARAJ P
JOHNSON AE
MCNEIL JG
MCCUTCHAN FE
CARR JK
Citation: N. Sirisopana et al., CORRELATES OF HIV-1 SEROPOSITIVITY AMONG YOUNG MEN IN THAILAND, Journal of acquired immune deficiency syndromes and human retrovirology, 11(5), 1996, pp. 492-498
Authors:
MASCOLA JR
LOUDER MK
SURMAN SR
VANCOTT TC
YU XF
BRADAC J
PORTER KR
NELSON KE
GIRARD M
MCNEIL JG
MCCUTCHAN FE
BIRX DL
BURKE DS
Citation: Jr. Mascola et al., HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NEUTRALIZING ANTIBODY SEROTYPING USING SERUM POOLS AND AN INFECTIVITY REDUCTION ASSAY, AIDS research and human retroviruses, 12(14), 1996, pp. 1319-1328
Authors:
SALMINEN MO
JOHANSSON B
SONNERBORG A
AYEHUNIE S
GOTTE D
LEINIKKI P
BURKE DS
MCCUTCHAN FE
Citation: Mo. Salminen et al., FULL-LENGTH SEQUENCE OF AN ETHIOPIAN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) ISOLATE OF GENETIC SUBTYPE C, AIDS research and human retroviruses, 12(14), 1996, pp. 1329-1339
Authors:
MICHAEL NL
DAVIS KE
LOOMISPRICE LD
VANCOTT TC
BURKE DS
REDFIELD RR
BIRX DL
Citation: Nl. Michael et al., V3 SEROREACTIVITY AND SEQUENCE VARIATION - TRACKING THE EMERGENCE OF V3 GENOTYPIC VARIATION IN HIV-1-INFECTED PATIENTS, AIDS, 10(2), 1996, pp. 121-129
Authors:
LEVINE BL
MOSCA JD
RILEY JL
CARROLL RG
VAHEY MT
JAGODZINSKI LL
WAGNER KF
MAYERS DL
BURKE DS
WEISLOW OS
STLOUIS DC
JUNE CH
Citation: Bl. Levine et al., ANTIVIRAL EFFECT AND EX-VIVO CD4(-CELL PROLIFERATION IN HIV-POSITIVE PATIENTS AS A RESULT OF CD28 COSTIMULATION() T), Science, 272(5270), 1996, pp. 1939-1943
Citation: Ds. Burke, AUZIAS-TURENNE,JOSEPH-ALEXANDRE, PASTEUR,LOUIS, AND EARLY CONCEPTS OFVIRULENCE, ATTENUATION, AND VACCINATION, Perspectives in biology and medicine, 39(2), 1996, pp. 171-186
Authors:
BROWN AE
JACKSON JN
NEWBY JH
BURKE DS
RAY KL
Citation: Ae. Brown et al., PREVENTION AND TREATMENT OF HIV-INFECTIONS IN MINORITIES IN THE US MILITARY - A REVIEW OF MILITARY RESEARCH, Military medicine, 161(2), 1996, pp. 123-127
Authors:
CARR JK
SALMINEN MO
KOCH C
GOTTE D
ARTENSTEIN AW
HEGERICH PA
STLOUIS D
BURKE DS
MCCUTCHAN FE
Citation: Jk. Carr et al., FULL-LENGTH SEQUENCE AND MOSAIC STRUCTURE OF A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATE FROM THAILAND, Journal of virology, 70(9), 1996, pp. 5935-5943
Authors:
MCCUTCHAN FE
ARTENSTEIN AW
SANDERSBUELL E
SALMINEN MO
CARR JK
MASCOLA JR
YU XF
NELSON KE
KHAMBOONRUANG C
SCHMITT D
KIENY MP
MCNEIL JG
BURKE DS
Citation: Fe. Mccutchan et al., DIVERSITY OF THE ENVELOPE GLYCOPROTEIN AMONG HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES OF CLADE-E FROM ASIA AND AFRICA, Journal of virology, 70(6), 1996, pp. 3331-3338
Authors:
WONG MT
DOLAN MJ
KOZLOW E
DOE R
MELCHER GP
BURKE DS
BOSWELL RN
VAHEY M
Citation: Mt. Wong et al., PATTERNS OF VIRUS BURDEN AND T-CELL PHENOTYPE ARE ESTABLISHED EARLY AND ARE CORRELATED WITH THE RATE OF DISEASE PROGRESSION IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED PERSONS, The Journal of infectious diseases, 173(4), 1996, pp. 877-887
Authors:
MASCOLA JR
SNYDER SW
WEISLOW OS
BELAY SM
BELSHE RB
SCHWARTZ DH
CLEMENTS ML
DOLIN R
GRAHAM BS
GORSE GJ
KEEFER MC
MCELRATH MJ
WALKER MC
WAGNER KF
MCNEIL JG
MCCUTCHAN FE
BURKE DS
Citation: Jr. Mascola et al., IMMUNIZATION WITH ENVELOPE SUBUNIT VACCINE PRODUCTS ELICITS NEUTRALIZING ANTIBODIES AGAINST LABORATORY-ADAPTED BUT NOT PRIMARY ISOLATES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1, The Journal of infectious diseases, 173(2), 1996, pp. 340-348
Authors:
RENZULLO PO
MCNEIL JG
WANN ZF
BURKE DS
BRUNDAGE JF
Citation: Po. Renzullo et al., HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SEROCONVERSION TRENDS AMONG YOUNG-ADULTS SERVING IN THE UNITED-STATES-ARMY, 1985-1993, Journal of acquired immune deficiency syndromes and human retrovirology, 10(2), 1995, pp. 177-185